The SNCA Gene PARK4 Parkinson Genetic Test is a specialized diagnostic tool designed to identify mutations in the SNCA gene, which are associated with the development of Parkinson's disease, specifically the PARK4 variant. This genetic test is crucial for individuals with a family history of Parkinson's disease or those who show early symptoms, as it can provide valuable insights into their risk of developing this neurodegenerative disorder.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves a detailed analysis of the SNCA gene to detect abnormalities that could lead to Parkinson's disease. The process is straightforward, requiring a simple sample of DNA, usually obtained from a blood draw or cheek swab.
The cost of the SNCA Gene PARK4 Parkinson Genetic Test at DNA Labs UAE is 4400 AED. Although the price may seem high, the test offers potentially invaluable information for individuals and families at risk, enabling early intervention strategies and personalized management plans to mitigate the impact of Parkinson's disease.
The UCHL1 Gene PARK5 Parkinson Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the UCHL1 gene, which have been associated with a rare familial form of Parkinson's disease. This gene plays a crucial role in the pathogenesis of Parkinson's disease by influencing the ubiquitin-proteasome system, crucial for protein degradation and clearance in neural cells. Mutations in the UCHL1 gene can lead to abnormal protein accumulation, contributing to neurodegeneration observed in Parkinson's disease.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing techniques. The aim is to detect any genetic alterations in the UCHL1 gene that may indicate an increased risk of developing Parkinson's disease, particularly in individuals with a family history of the condition.
By identifying these genetic markers early, the UCHL1 Gene PARK5 Parkinson Genetic Test can provide crucial information for risk assessment and potential early intervention strategies. It's an important tool in the management and understanding of Parkinson's disease, offering hope for those seeking to understand their genetic predisposition to this challenging neurodegenerative disorder.
The PINK1 Gene PARK6 Parkinson Genetic Test is a specialized diagnostic examination designed to detect mutations in the PTEN-induced kinase 1 (PINK1) gene, which is associated with PARK6, a form of early-onset Parkinson's disease. This genetic test is crucial for individuals with a family history of Parkinson's disease or those who exhibit symptoms at an early age, as it can provide definitive information regarding their genetic predisposition to this form of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis to identify the specific mutations in the PINK1 gene that are linked to the development of Parkinson's disease. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify and interpret the genetic variations associated with the condition. This test not only aids in the early diagnosis and understanding of the patient's condition but also in the planning of personalized management and treatment strategies, potentially improving the quality of life for those affected by this form of Parkinson's disease.
The "EOMES Gene Neuronal Migration Disorder Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the EOMES gene, which are linked to various neuronal migration disorders. These disorders can affect brain development, leading to a range of neurological symptoms and conditions. The EOMES gene plays a crucial role in the development and migration of neurons during embryonic brain development. Mutations in this gene can disrupt normal brain formation, resulting in developmental delays, intellectual disabilities, and other neurological issues.
This genetic test involves analyzing the patient's DNA to detect any abnormalities in the EOMES gene that may be responsible for such conditions. It is a critical step in diagnosing specific neuronal migration disorders, allowing for a better understanding of the condition and enabling healthcare providers to tailor treatment and management plans more effectively.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the EOMES Gene Neuronal Migration Disorder Genetic Test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this intricate analysis. By offering this test, DNA Labs UAE provides essential support for individuals and families seeking answers to complex neurological conditions, contributing to improved patient care and outcomes in the field of genetic disorders.
The SPTBN5 gene neuronal migration disorder genetic test is a specialized diagnostic procedure aimed at detecting mutations in the SPTBN5 gene, which have been associated with disorders affecting neuronal migration. Neuronal migration disorders are a group of conditions that occur when nerve cells (neurons) do not move to their correct location in the developing brain during early fetal development. This can lead to a variety of neurological and developmental problems, including intellectual disabilities, epilepsy, and motor disorders.
This test, performed at DNA Labs UAE, uses advanced genetic sequencing technologies to analyze the SPTBN5 gene for any abnormalities that might be linked to these disorders. By identifying specific genetic mutations, healthcare providers can make accurate diagnoses, better understand the condition's prognosis, and in some cases, offer targeted treatments or interventions that can improve patient outcomes.
The cost of the SPTBN5 gene neuronal migration disorder genetic test at DNA Labs UAE is 4400 AED. This price reflects the intricate process of genetic analysis and the expertise required to interpret the results accurately. For families and individuals facing the challenges associated with neuronal migration disorders, this test represents a crucial step towards obtaining a clear diagnosis and the possibility of personalized care planning.
The SRGAP2 Gene Neuronal Migration Disorder Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the SRGAP2 gene, which are known to affect neuronal migration during brain development. This condition can lead to a range of neurological disorders, impacting an individual's cognitive function, motor skills, and overall brain structure. The test is crucial for early detection and management of associated conditions, providing essential information for personalized treatment plans.
Conducted through advanced genetic sequencing techniques, this test analyzes the patient's DNA to pinpoint any abnormalities within the SRGAP2 gene. The process is non-invasive, requiring only a sample of the patient's blood or saliva. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in this specific gene.
By opting for the SRGAP2 Gene Neuronal Migration Disorder Genetic Test at DNA Labs UAE, patients and their families can gain valuable insights into potential neurological conditions, enabling them to seek timely intervention and support.
The HSPB8 gene neuronopathy distal hereditary motor type 2A (dHMN2A) genetic test is a specialized diagnostic tool used to identify mutations in the HSPB8 gene, which are associated with distal hereditary motor neuronopathy type 2A. This condition is a rare genetic disorder characterized by progressive weakness and atrophy of the muscles in the hands and feet, often leading to significant disability. The test is crucial for confirming the diagnosis, understanding the inheritance pattern, and guiding management and treatment options for affected individuals.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to look for specific genetic alterations in the HSPB8 gene that are known to cause dHMN2A. This is achieved through advanced genetic sequencing techniques that ensure accuracy and reliability of the results. The cost of the test is 4400 AED, which reflects the comprehensive nature of the genetic analysis and the expertise required to interpret the results.
By identifying the genetic basis of the condition, the test not only helps in confirming the diagnosis but also assists in family planning and provides insights into the prognosis of the disorder. It is a vital tool for healthcare professionals managing patients with suspected dHMN2A, enabling them to offer personalized care and support to individuals and their families affected by this challenging condition.
The HSPB1 Gene Neuronopathy Distal Hereditary Motor Type 2B Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the HSPB1 gene, which are linked to the development of Distal Hereditary Motor Neuronopathy Type 2B (dHMN2B). This condition is a rare genetic disorder characterized by progressive weakness and atrophy of the distal muscles, primarily affecting the lower limbs and, in some cases, the upper limbs. The test is critical for individuals with clinical symptoms suggestive of dHMN2B or those with a family history of the condition, as it provides definitive genetic evidence for accurate diagnosis, prognosis, and potential management strategies.
The genetic test involves collecting a DNA sample, typically through a blood draw, which is then analyzed for specific mutations in the HSPB1 gene known to cause the condition. The result from this test can guide healthcare professionals in developing personalized treatment plans and offer genetic counseling to affected individuals and their families regarding the inheritance patterns and risks for future offspring.
The cost of the HSPB1 Gene Neuronopathy Distal Hereditary Motor Type 2B Genetic Test at DNA Labs UAE is set at 4400 AED. This cost encompasses the technical process of genetic sequencing and the professional analysis required to interpret the results accurately. Given the specialized nature of this test and its significance in the diagnosis and management of dHMN2B, it represents a crucial investment for individuals seeking clarity on their genetic status concerning this rare neurodegenerative condition.
The GARS1 Gene Neuronopathy Distal Hereditary Motor Type 5 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GARS1 gene, which are implicated in the development of Distal Hereditary Motor Neuronopathy Type V (dHMN-V). This condition is a rare genetic disorder characterized by progressive weakness and atrophy of the distal muscles, primarily affecting the limbs. The GARS1 gene plays a crucial role in the development and function of peripheral neurons, and mutations can lead to the disruption of these processes, manifesting in the clinical symptoms of dHMN-V.
The test involves the collection of a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing techniques to detect the presence of mutations in the GARS1 gene. It is a vital tool for clinicians in confirming a diagnosis, allowing for a better understanding of the condition, and facilitating informed decisions regarding management and treatment options.
At DNA Labs UAE, the cost of the GARS1 Gene Neuronopathy Distal Hereditary Motor Type 5 Genetic Test is set at 4400 AED. This price reflects the sophisticated nature of the testing process and the specialized expertise required to interpret the results accurately. For patients and families affected by this condition, the test represents a crucial step towards achieving a definitive diagnosis and accessing appropriate care and support.
The IGHMBP2 gene neuronopathy, also known as Distal Hereditary Motor Neuropathy Type 6 (dHMN-VI), is a rare genetic disorder that primarily affects the peripheral nerves, leading to muscle weakness and atrophy predominantly in the distal limbs. It is caused by mutations in the IGHMBP2 gene, which plays a crucial role in the maintenance and function of motor neurons. The disorder is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this condition, genetic testing is essential. DNA Labs UAE offers a specific genetic test for the IGHMBP2 gene neuronopathy. The test is designed to detect mutations in the IGHMBP2 gene that are responsible for the condition. This precise genetic testing is crucial for the accurate diagnosis of Distal Hereditary Motor Neuropathy Type 6, enabling affected individuals and their families to understand their condition better and to explore potential treatment and management options.
The cost of the IGHMBP2 gene neuronopathy genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the presence of the specific genetic mutations in the IGHMBP2 gene. By choosing to undergo this genetic testing, individuals can gain valuable insights into their genetic makeup, facilitating informed decisions regarding their health and future care plans.
